Archives
Press Releases
advertisement
October 3, 2018
- Results from Two Phase 3 Studies Show Lilly’s Ultra Rapid Lispro (URLi) Met Primary Efficacy Endpoint in People with Type 1 and Type 2 Diabetes. See also Ultra-rapid insulin improves postprandial glucose levels in type 1, type 2 diabetes.
- Health Canada approves TRESIBA® for children with Type 1 diabetes.
- Abbott′s FreeStyle® Libre 2, with Optional Real-Time Alarms, Secures CE Mark for Use in Europe.
- Beyond Type 1 Receives $300,985 Helmsley Charitable Trust Grant for DKA Awareness Campaign.
September 12, 2018
August 22, 2018
- Tandem Diabetes Care Announces Commercial Launch of t:slim X2 Insulin Pump with Basal-IQ Technology in the United States.
- Ziylo Acquired by Novo Nordisk in Deal That Could Exceed US$800m. See also Bristol university PhD graduate, 31, set to become a multi-millionaire after company he co-founded sells for £600 million and Bristol University graduate sells Ziylo firm in deal worth £623m.
- AADE’s DANA: One-Stop Healthcare Technology Resource for Diabetes Educators.
- Companion Medical and One Drop Announce Partnership in Integrated Diabetes Management.
advertisement
